best performing stocks in the mid cap june 2025 to 2026

AXT (AXTI) has had the highest return between June 1, 2025 and December 31, 2026 by a mid-cap US stock, returning 3,522.4%.

ASSETDATE% RETURN
AXT (AXTI)
6/1/2025 - 12/31/2026
3,522.37%
Kodiak Sciences (KOD)
6/1/2025 - 12/31/2026
2,843.03%
Abivax SA American Depositary Shares (ABVX)
6/1/2025 - 12/31/2026
1,310.26%
Erasca (ERAS)
6/1/2025 - 12/31/2026
910.56%
Tango Therapeutics (TNGX)
6/1/2025 - 12/31/2026
909.78%
Oruka Therapeutics (ORKA)
6/1/2025 - 12/31/2026
780.64%
Praxis Precision Medicines  (PRAX)
6/1/2025 - 12/31/2026
633.15%
10X Genomics (TXG)
6/1/2025 - 12/31/2026
629.55%
Celcuity LLC (CELC)
6/1/2025 - 12/31/2026
546.07%
Spyre Therapeutics (SYRE)
6/1/2025 - 12/31/2026
527.01%
Relay Therapeutics  (RLAY)
6/1/2025 - 12/31/2026
511.67%
Abcellera Biologics  (ABCL)
6/1/2025 - 12/31/2026
507.43%
MaxLinear (MXL)
6/1/2025 - 12/31/2026
491.32%
Palvella Therapeutics (PVLA)
6/1/2025 - 12/31/2026
490.51%
Amylyx Pharmaceuticals (AMLX)
6/1/2025 - 12/31/2026
457.14%
Cogent Biosciences (COGT)
6/1/2025 - 12/31/2026
437.61%
Okeanis Eco Tankers (ECO)
6/1/2025 - 12/31/2026
437.37%
Precigen (PGEN)
6/1/2025 - 12/31/2026
421.8%
CareDx (CDNA)
6/1/2025 - 12/31/2026
413.27%
Fortrea (FTRE)
6/1/2025 - 12/31/2026
397.43%
Iovance Biotherapeutics (IOVA)
6/1/2025 - 12/31/2026
393.02%
Figs (FIGS)
6/1/2025 - 12/31/2026
392.15%
Definium Therapeutics (DFTX)
6/1/2025 - 12/31/2026
388.96%
PACS (PACS)
6/1/2025 - 12/31/2026
386.37%
Septerna, Inc Common Stock (SEPN)
6/1/2025 - 12/31/2026
371.6%
Mid-cap stocks are treated as having a market cap between $2B and $10B.